← Leaderboards
Tracy T Batchelor
Dana-Farber Cancer Inst
$27,819,477
Attributed
$30,236,945
Total exposure
41
Grants
41
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.7M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$63,324,238 · 43
By mechanism
P50$35,556,722 · 25
K12$10,755,801 · 1
R01$6,156,670 · 1
U19$6,047,453 · 5
K24$1,872,985 · 1
T32$1,616,678 · 1
Top collaborators
- Scott R Plotkin4 shared
- Michael E Greenberg3 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Kira Gritsman$6,960,355
- Bruce M Spiegelman$59,708,812
- Rani E George$9,003,170
- Nathanael Schiander Gray$36,761,550
- Donald W. Kufe$50,160,456
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsFundingResearch PersonnelClinical TrialsGliomaGlioblastomaCancer CenterImageResponseTumorGrantBaseTargeted TreatmentMalignant NeoplasmsWomanAwardCollaborationsScientistAdultResourcesNeuro-OncologyInstitutionMonitorRecurrence
Grant awards (139)
Targeted Therapies for Glioma$2,442,975
P50 · FY2025 · CA · contact PI
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma$942,190
U19 · FY2025 · CA · contact PI
Cancer Neuroscience Training Program$569,601
T32 · FY2025 · CA · contact PI
Administrative Core$302,140
P50 · FY2025 · CA · contact PI
Targeting metabolic vulnerabilities in Astrocytoma, IDH-mutant, Grade 4$191,298
U19 · FY2025 · CA · contact PI
Administrative Core$121,897
U19 · FY2025 · CA · contact PI
Developmental Research Program$89,500
P50 · FY2025 · CA · contact PI
Career Enhancement Program$89,500
P50 · FY2025 · CA · contact PI
Program 30: Neuro-Oncology$61,588
P30 · FY2025 · CA · contact PI
Targeted Therapies for Glioma$2,539,918
P50 · FY2024 · CA · contact PI
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma$836,753
U19 · FY2024 · CA · contact PI
Cancer Neuroscience Training Program$550,907
T32 · FY2024 · CA · contact PI
Administrative Core$293,657
P50 · FY2024 · CA · contact PI
Targeting metabolic vulnerabilities in Astrocytoma, IDH-mutant, Grade 4$169,626
U19 · FY2024 · CA · contact PI
Administrative Core$103,694
U19 · FY2024 · CA · contact PI
Developmental Research Program$85,920
P50 · FY2024 · CA · contact PI
Career Enhancement Program$85,919
P50 · FY2024 · CA · contact PI
Program 30: Neuro-Oncology$42,057
P30 · FY2024 · CA · contact PI
SPORE: Targeted Therapies for Glioma$2,207,927
P50 · FY2023 · CA · contact PI
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma$864,597
U19 · FY2023 · CA · contact PI
Cancer Neuroscience Training Program$496,170
T32 · FY2023 · CA · contact PI
Administration - Core C$339,555
P50 · FY2023 · CA · contact PI
SPORE: Targeted Therapies for Glioma$234,721
P50 · FY2023 · CA · contact PI
Targeting metabolic vulnerabilities in Astrocytoma, IDH-mutant, Grade 4$176,218
U19 · FY2023 · CA · contact PI
Administrative Core$108,157
U19 · FY2023 · CA · contact PI
Career-Enh-Prog-001$93,650
P50 · FY2023 · CA · contact PI
Dev-Res-Prog-001$93,650
P50 · FY2023 · CA · contact PI
Program 30: Neuro-Oncology$43,241
P30 · FY2023 · CA · contact PI
SPORE: Targeted Therapies for Glioma$2,250,039
P50 · FY2022 · CA · contact PI
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma$859,930
U19 · FY2022 · CA · contact PI
Training Program in Nervous System Tumors$803,929
K12 · FY2022 · CA
Administration - Core C$339,555
P50 · FY2022 · CA · contact PI
Project-008$252,388
P50 · FY2022 · CA · contact PI
SPORE: Targeted Therapies for Glioma - Diversity Supplement$252,388
P50 · FY2022 · CA · contact PI
Project-007$240,300
P50 · FY2022 · CA · contact PI
SPORE: Targeted Therapies for Glioma$240,300
P50 · FY2022 · CA · contact PI
Targeting metabolic vulnerabilities in Astrocytoma, IDH-mutant, Grade 4$170,339
U19 · FY2022 · CA · contact PI
Administrative Core$106,696
U19 · FY2022 · CA · contact PI
Dev-Res-Prog-001$93,649
P50 · FY2022 · CA · contact PI
Career-Enh-Prog-001$93,649
P50 · FY2022 · CA · contact PI
Program 30: Neuro-Oncology$43,239
P30 · FY2022 · CA · contact PI
SPORE: Targeted Therapies for Glioma$2,252,175
P50 · FY2021 · CA · contact PI
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma$1,014,545
U19 · FY2021 · CA · contact PI
Training Program in Nervous System Tumors$803,929
K12 · FY2021 · CA
Administration - Core C$260,505
P50 · FY2021 · CA · contact PI
SPORE: Targeted Therapies for Glioma$244,260
P50 · FY2021 · CA · contact PI
Administration - Core C$244,260
P50 · FY2021 · CA · contact PI
Targeting metabolic vulnerabilities in Astrocytoma, IDH-mutant, Grade 4$195,042
U19 · FY2021 · CA · contact PI
Administrative Core$186,471
U19 · FY2021 · CA · contact PI
Career-Enh-Prog-001$83,555
P50 · FY2021 · CA · contact PI
Dev-Res-Prog-001$83,555
P50 · FY2021 · CA · contact PI
Program 30: Neuro-Oncology$73,823
P30 · FY2021 · CA · contact PI
Annual Meeting of the International Primary CNS Lymphoma Collaborative Group (IPCG)$5,000
R13 · FY2021 · CA · contact PI
SPORE: Targeted Therapies for Glioma$2,298,683
P50 · FY2020 · CA · contact PI
Training Program in Nervous System Tumors$805,200
K12 · FY2020 · CA · contact PI
Administration - Core C$265,672
P50 · FY2020 · CA · contact PI
SPORE: Targeted Therapies for Glioma - Diversity Supplement$264,010
P50 · FY2020 · CA · contact PI
Career-Enh-Prog-001$88,722
P50 · FY2020 · CA · contact PI
Dev-Res-Prog-001$88,722
P50 · FY2020 · CA · contact PI
SPORE: Targeted Therapies for Glioma$2,438,174
P50 · FY2019 · CA · contact PI
Training Program in Nervous System Tumors$805,200
K12 · FY2019 · CA · contact PI
Administration - Core C$359,304
P50 · FY2019 · CA · contact PI
Career-Enh-Prog-001$93,651
P50 · FY2019 · CA · contact PI
Dev-Res-Prog-001$93,651
P50 · FY2019 · CA · contact PI
Annual International Primary CNS Lymphoma Collaborative Group Meeting$5,000
R13 · FY2019 · CA · contact PI
Training Program in Nervous System Tumors$805,200
K12 · FY2018 · CA · contact PI
Annual International Primary CNS Lymphoma Collaborative Group Meeting$5,000
R13 · FY2018 · CA · contact PI
SPORE: Targeted Therapies for Glioma$2,280,112
P50 · FY2017 · CA · contact PI
Training Program in Nervous System Tumors$805,200
K12 · FY2017 · CA · contact PI
Angiogenesis-targeting therapy for glioblastoma$592,913
R01 · FY2017 · CA · contact PI
Targeting the Vascular System$286,019
P50 · FY2017 · CA · contact PI
Administrative Core$268,582
P50 · FY2017 · CA · contact PI
Angiogenesis-targeting therapy for glioblastoma$251,370
R01 · FY2017 · CA · contact PI
Development Research Project$70,695
P50 · FY2017 · CA · contact PI
Career Development Research Project$70,695
P50 · FY2017 · CA · contact PI
Annual International Primary CNS Lymphoma Collaborative Group Meeting$5,000
R13 · FY2017 · CA · contact PI
SPORE: Targeted Therapies for Glioma$2,162,000
P50 · FY2016 · CA · contact PI
Training Program in Nervous System Tumors$805,200
K12 · FY2016 · CA · contact PI
Angiogenesis-targeting therapy for glioblastoma$592,913
R01 · FY2016 · CA · contact PI
Targeting the Vascular System$272,833
P50 · FY2016 · CA · contact PI
Administrative Core$255,430
P50 · FY2016 · CA · contact PI
Clinical and Molecular Studies of Malignant Brain Tumors$185,972
K24 · FY2016 · CA · contact PI
Angiogenesis-targeting therapy for glioblastoma$173,281
R01 · FY2016 · CA · contact PI
Development Research Project$57,914
P50 · FY2016 · CA · contact PI
Career Development Research Project$57,914
P50 · FY2016 · CA · contact PI
Annual International Primary CNS Lymphoma Collaborative Group Meeting$2,500
R13 · FY2016 · CA · contact PI
SPORE: Targeted Therapies for Glioma$2,166,955
P50 · FY2015 · CA · contact PI
Training Program in Nervous System Tumors$774,522
K12 · FY2015 · CA · contact PI
Angiogenesis-targeting therapy for glioblastoma$575,734
R01 · FY2015 · CA · contact PI
Targeting the Vascular System$397,281
P50 · FY2015 · CA · contact PI
Clinical and Molecular Studies of Malignant Brain Tumors$185,972
K24 · FY2015 · CA · contact PI
Administrative Core$53,239
P50 · FY2015 · CA · contact PI
SPORE: Targeted Therapies for Glioma$2,144,141
P50 · FY2014 · CA · contact PI
Training Program in Nervous System Tumors$764,863
K12 · FY2014 · CA · contact PI
Angiogenesis-targeting therapy for glioblastoma$361,430
R01 · FY2014 · CA · contact PI
Targeting the Vascular System$321,988
P50 · FY2014 · CA · contact PI
Clinical and Molecular Studies of Malignant Brain Tumors$185,972
K24 · FY2014 · CA · contact PI
Administrative Core$68,200
P50 · FY2014 · CA · contact PI
Annual International Primary CNS Lymphoma Collaborative Group Meeting$5,000
R13 · FY2014 · CA · contact PI
SPORE: Targeted Therapies for Glioma$2,150,500
P50 · FY2013 · CA · contact PI
Training Program in Nervous System Tumors$748,643
K12 · FY2013 · CA · contact PI
Angiogenesis-targeting therapy for glioblastoma$594,234
R01 · FY2013 · CA · contact PI
Targeting the Vasular System$276,199
P50 · FY2013 · CA · contact PI
Administration Core$258,580
P50 · FY2013 · CA · contact PI
Clinical and Molecular Studies of Malignant Brain Tumors$185,972
K24 · FY2013 · CA · contact PI
Developmental Research Program$58,623
P50 · FY2013 · CA · contact PI
Career Development Program$58,623
P50 · FY2013 · CA · contact PI
Annual International Primary CNS Lymphoma Collaborative Group Meeting$7,000
R13 · FY2013 · CA · contact PI
Training Program in Nervous System Tumors$764,863
K12 · FY2012 · CA · contact PI
Clinical and Molecular Studies of Malignant Brain Tumors$185,972
K24 · FY2012 · CA · contact PI
Annual International Primary CNS Lymphoma Collaborative Group Meeting$7,500
R13 · FY2012 · CA · contact PI
Training Program in Nervous System Tumors$767,105
K12 · FY2011 · CA · contact PI
AZD2171 and chemoradiation for newly diagnosed glioblastoma$607,551
R01 · FY2011 · CA · contact PI
Clinical and Molecular Studies of Novel Therapeutics in Malignant Brain Tumors$191,011
K24 · FY2011 · CA · contact PI
AZD2171 and chemoradiation for newly diagnosed glioblastoma$636,689
R01 · FY2010 · CA · contact PI
Training Program in Nervous System Tumors$518,992
K12 · FY2010 · CA · contact PI
Clinical and Molecular Studies of Novel Therapeutics in Malignant Brain Tumors$189,955
K24 · FY2010 · CA · contact PI
Annual Primary CNS Lymphoma Collaborative Group Meeting$5,000
R13 · FY2010 · CA · contact PI
AZD2171 and chemoradiation for newly diagnosed glioblastoma$634,655
R01 · FY2009 · CA · contact PI
Training Program in Nervous System Tumors$263,963
K12 · FY2009 · CA · contact PI
Clinical and Molecular Studies of Novel Therapeutics in Malignant Brain Tumors$188,930
K24 · FY2009 · CA · contact PI
Annual Primary CNS Lymphoma Collaborative Group Meeting$5,000
R13 · FY2009 · CA · contact PI
AZD2171 and chemoradiation for newly diagnosed glioblastoma$583,728
R01 · FY2008 · CA · contact PI
Training Program in Nervous System Tumors$518,992
K12 · FY2008 · CA · contact PI
Clinical and Molecular Studies of Novel Therapeutics in Malignant Brain Tumors$187,934
K24 · FY2008 · CA · contact PI
NABTT-New Approaches to Brain Tumor Therapy (CNSC)$57,838
U01 · FY2008 · CA · contact PI
Annual Primary CNS Lymphoma Collaborative Group Meeting$5,000
R13 · FY2008 · CA · contact PI
CLINICAL TRIAL: A PHASE 2 STUDY OF AZD2171 IN RECURRENT GLIOBLASTOMA (NCI PROTOC$1,295
M01 · FY2008 · RR · contact PI
AZD2171 and chemoradiation for newly diagnosed glioblastoma$552,172
R01 · FY2007 · CA · contact PI
Clinical and Molecular Studies of Novel Therapeutics in Malignant Brain Tumors$185,295
K24 · FY2007 · CA · contact PI
NABTT-New Approaches to Brain Tumor Therapy (CNSC)$57,263
U01 · FY2007 · CA · contact PI
A PHASE 2 STUDY OF AZD2171 IN RECURRENT GLIOBLASTOMA (NCI PROTOCOL #7105)$18,003
M01 · FY2007 · RR · contact PI
Annual Primary CNS Lymphoma Collaborative Group Meeting$5,000
R13 · FY2007 · CA · contact PI
A Phase 2 study of AZD2171 in Recurrent Glioblastoma$337,503
R21 · FY2006 · CA · contact PI
NABTT-New Approaches to Brain Tumor Therapy (CNSC)$57,257
U01 · FY2006 · CA · contact PI
Annual Primary CNS Lymphoma Collaborative Group Meeting$5,000
R13 · FY2006 · CA · contact PI
A Phase 2 study of AZD2171 in Recurrent Glioblastoma$345,625
R21 · FY2005 · CA
NABTT-New Approaches to Brain Tumor Therapy (CNSC)$56,928
U01 · FY2005 · CA
NABTT-New Approaches to Brain Tumor Therapy (CNSC)$55,269
U01 · FY2004 · CA